SC
TMCI icon

Savant Capital’s Treace Medical Concepts TMCI Stock Holding History

Savant Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,394
Closed -$104K – 1274
2025
Q1 		$104K Buy
+12,394
New +$111K ﹤0.01% 1035
2024
Q4 		– Sell
-11,102
Closed -$64.4K – 1507
2024
Q3 		$64.4K Sell
11,102
-2,863
-21% -$18.4K ﹤0.01% 1364
2024
Q2 		$92.9K Buy
+13,965
New +$113K ﹤0.01% 1210

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Savant Capital's TMCI Position: Q2 2025 in Review

Savant Capital sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 12,394 shares — an estimated $104K sold.

Savant Capital first reported a position in TMCI in Q2 2024 and held it in 3 quarters. The position peaked at $104K in Q1 2025. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Savant Capital reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Savant Capital sold 12,394 Treace Medical Concepts shares in Q2 2025, an estimated $104K.
  • Savant Capital first reported a position in Treace Medical Concepts in Q2 2024 and held it in 3 quarters.
  • Savant Capital's Treace Medical Concepts position peaked at $104K in Q1 2025.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Savant Capital's 13F filing for Q2 2025, filed 6 Aug 2025.